echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Step Pharmaceuticals four-price influenza virus lysing vaccine approved for clinical trials

    Step Pharmaceuticals four-price influenza virus lysing vaccine approved for clinical trials

    • Last Update: 2021-03-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    January 4, Step Pharmaceuticals announced that its controlling subsidiary, Zhejiang Tianyuan Biopharmaceutical Co., Ltd., had recently received a "Drug Clinical Trial Approval Notice" for the four-price influenza virus lysed vaccine approved by the State Drug Administration.The four-price influenza virus lysate vaccine is mainly used to stimulate the body to produce anti-influenza virus immunity, to prevent influenza caused by this strain. According to Minanet statistics, the amount of china's influenza virus lysation vaccine conversion approval in 2018 was 481.72 million yuan, and in 2019 China's influenza virus lyse vaccine conversion approval amounted to 967.2 million yuan, an increase of 101% over 2018.Up to now, the cumulative investment in research and development costs of the product is about 33.8137 million yuan. (
    Sina Pharmaceutical News
    )
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.